| 000 | 01299 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517083550.0 | ||
| 264 | 0 | _c20171226 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdw100 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStjepanovic, N | |
| 245 | 0 | 0 |
_aOcular toxicities of MEK inhibitors and other targeted therapies. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c06 2016 |
||
| 300 |
_a998-1005 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aRetinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aVelazquez-Martin, J P | |
| 700 | 1 | _aBedard, P L | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 27 _gno. 6 _gp. 998-1005 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdw100 _zAvailable from publisher's website |
| 999 |
_c25803808 _d25803808 |
||